It takes a special type of coward to rip on a guy that has you on ignore.
We all on this board have come to know you as a negative short shill with nothing to contribute but drivel that wants to drive the stock down in price. You do not know what it would be like to say those cowardly things to my face so you are left to expound on all things ridiculous behind my back as you will remain on ignore forever. Do these cowardly comments make you succesful, smart, tough or well liked?
None of these apply to you
Last gasps of the shorties coming out, half of my page on ignore now quiets things greatly, I am ready to hear of Optina over the next day or two.
Wait till the Optina news comes out, then we shall continue this trend of price appreciation in parallel with the recognition of the efficacy of Ampion and Optina.
I'm thinking we win~
If I needed a total knee replacement and I participated in a trial somewhere with a few shots and three months later I am able to report 95% improvement in pain I'm thinking I'm nearly cured what are you thinking now haters, shorties, charty geeks, watcha thinking now huh?
Not yet, the mgt has always stated that MRI data would be read by an outside professional and will be also reported shortly for the 20 week segment of the super 7! So the statement did mention a tremendous level of pain relief, are you happy about that Mr. Bill?
As the molecules we know about do not do anything to deaden nerve pain, but do work in an antiinflamitory way, the only way that these molecules will relieve pain is if the cartilage returns. That seems like common sense, however a known level of pain relief at the stated primary end point was 95% at 12 weeks vs. 42% at same point for single injection. So just three months into therapy and the people have almost NO KNEE PAIN. Blockbuster in the making......
Are you happy about that Mr. Bill?
Yes, you are right, I have been a bit harsh today, but it took a while for this vindication to give me a brief moment to lash back at the haters who have talked smack about Ampio for many many months now for no reason other than cheesedik frozen samples, that was the only reason we went from 9 to the threes, now we outa be right back at the nines unless these haters continue to breath baloney here on this board.
I do thank you for telling me to chill out nicely, so then I apologize to those who might not want to read my retorts to the haters. Everything I write is true however, and those who were haters know it.
The story never changed even years ago from a thousand trail participants down to the seven in question, so when a very very new person in the company options-- not the stock but the options, when a very new person says the company got its street cred back I have to wonder why all the noise?
It would have been impossible for you to hold these ideals months ago, like I did, These positives were always present and you chose to ignore them so many times, you in fact reported at length just the opposite many times......now you are agreeing with MM on the value of the company?
Anyway, good day to be a long. I know you have been around here a long time so to you and others I say patience has it's rewards.
Hmm, thought several days ago you and Mr. Bill were conspiring to tell us that we'd wait six more months for open label reporting..... basically you two, while informed are sure wishy washy..... Credibility is a costly thing to lose.
Whut do you know, to all the naysayers looks like today I was right on....
We should all and I mean all longs and shorts congratulate the management here for sticking to business, and not getting involved in all the bullsheit, to all the technical/chartist manipulators, and all the shortie geeks, and all the smelly fuerstein types, and all the fake lawyers with their fake lawsuits, and all the scientific naysayers....
I say good luck to you when you try to cover tomorrow, good luck because you won't get my shares for under $20. Put in very high limit sell orders and watch this stock fly, and this doesn't even include the Optina news to come, and the upgrades, and the institutional involvement after $5 per share, so this is a winner here, despite, Supers or Mr. Bills, or Improv's, or any of the other wishy washy types on this board.